Among the largest biopharmaceutical companies, New York-based Pfizer continues to grab headlines on the monumental development of its successful Covid vaccine, now called Comirnaty, with BioNTech.
Pfizer started as a manufacturer of fine chemicals by German cousins Charles Pfizer and Charles Earhart in 1849 in Brooklyn. They discovered citric acid, the ingredient in Coca-Cola and Pepsi.
Pfizer works across markets to develop wellness, prevention, treatments, and cures, providing access to healthcare through collaboration with governments, corporate partners, healthcare providers, and local communities.
We will provide you with some of the investing attributes as of January 18, 2022, from Yahoo Finance:– Market Capitalization: $303.6 Billion– Average Volume: 43,340,212– Trailing P/E Ratio (TTM): 15.45– Forward P/E Ratio: 11.07– 52 Week H/L Range: $33.36-$61.71– Dividend Yield: 2.96%– Beta: 0.64
Pfizer (PFE) is considered a large-cap stock with a market capitalization of over $300 billion and is included in the S&P 500 index and the S&P Healthcare sector.
The price-earnings or PE ratio is the current market price divided by the company’s earnings per share or EPS. This ratio is the primary benchmark of valuing a stock, demonstrating how expensive the shares are relative to the company’s profits.
Pfizer’s dividend yield is the annual cash dividend paid of $1.60 per share to an investor as a percentage of its current market price, or 2.96%. This yield is above average compared to the S&P 500’s rate.
The comparable peers that serve as Pfizer’s are:– Abbvie (ABBV)– Bristol Myers (BMY)– Eli Lilly (LLY)– Johnson & Johnson (JNJ)– Merck (MRK– Novartis (NVS)– Roche Holding (RHHBY)